In this study, we investigated the therapeutic potential of 125I seed implantation therapy as an alternative treatment modality for CCA, focusing on its ability to induce ROS-mediated apoptosis and the involvement of GPX2 in this process. The gene discussed is GPX2; the disease is cholangiocarcinoma.